Literature DB >> 26540607

Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.

Dumnoensun Pruksakorn1, Areerak Phanphaisarn2, Olarn Arpornchayanon3, Nantawat Uttamo2, Taninnit Leerapun2, Jongkolnee Settakorn4.   

Abstract

BACKGROUND: Osteosarcoma is a common and aggressive primary malignant bone tumor occurring in children and adolescents. It is one of the most aggressive human cancers and the most common cause of cancer-associated limb loss. As treatment in Thailand has produced a lower survival rate than in developed countries; therefore, this study identified survival rate and the poor prognostic factors of osteosarcoma in Northern Thailand.
METHODS: The retrospective cases of osteosarcoma, diagnosis between 1 January 1996 and 31 December 2013, were evaluated. Five and ten year overall survival rates were analyzed using time-to-event analysis. Potential prognostic factors were identified by multivariate regression analysis.
RESULTS: There were 208 newly diagnosed osteosarcomas during that period, and 144 cases met the criteria for analysis. The majority of the osteosarcoma cases (78.5%) were aged 0-24 years. The overall 5- and 10-year survival rates were 37.9% and 33.6%, respectively. Presence of metastasis at initial examination, delayed and against treatment co-operation, and axial skeletal location were identified as independent prognostic factors for survival, with hazard ratios of 4.3, 2.5 and 3.8, and 3.1, respectively.
CONCLUSIONS: This osteosarcoma cohort had a relatively poor overall survival rate. The prognostic factors identified would play a critical role in modifying survival rates of osteosarcoma patients; as rapid disease recognition, a better treatment counselling, as well as improving of chemotherapeutic regimens were found to be important in improving the overall survival rate in Thailand.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metastasis; Osteosarcoma; Patient compliance; Prognosis; Thailand

Mesh:

Year:  2015        PMID: 26540607     DOI: 10.1016/j.canep.2015.10.016

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  13 in total

1.  Factors Affecting Prognosis and Survival in Extremity Osteosarcoma.

Authors:  Anvesh Dharanikota; Ravi Arjunan; Ashwathappa Dasappa
Journal:  Indian J Surg Oncol       Date:  2021-01-06

2.  IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma.

Authors:  Parunya Chaiyawat; Areerak Phanphaisarn; Nutnicha Sirikaew; Jeerawan Klangjorhor; Viraporn Thepbundit; Pimpisa Teeyakasem; Phichayut Phinyo; Dumnoensun Pruksakorn; Jongkolnee Settakorn
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

3.  Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature.

Authors:  Dumnoensun Pruksakorn; Jatupon Kongthavonskul; Pimpisa Teeyakasem; Areerak Phanphaisarn; Parunya Chaiyawat; Jeerawan Klangjorhor; Olarn Arpornchayanon
Journal:  J Bone Oncol       Date:  2018-12-10       Impact factor: 4.072

4.  Treatment-Related Prognostic Factors in Managing Osteosarcoma around the Knee with Limb Salvage Surgery: A Lesson from a Long-Term Follow-Up Study.

Authors:  Jianping Hu; Chunlin Zhang; Kunpeng Zhu; Lei Zhang; Tao Cai; Taicheng Zhan; Xiong Luo
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

5.  Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database.

Authors:  Yue Pan; Daqi Chen; Taobo Hu; Guohua Lv; Zhehao Dai
Journal:  Cancer Control       Date:  2019 Jan-Dec       Impact factor: 3.302

6.  Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma.

Authors:  Kai Gao; Yingchun Zhang; Jianbing Niu; Zhikui Nie; Qingsheng Liu; Chaoliang Lv
Journal:  J Orthop Surg Res       Date:  2020-02-19       Impact factor: 2.359

7.  The extremity localized classic osteosarcomas have better survival than the axial non-classics.

Authors:  Li Lin; Shaoyong Deng; Futing Zhang; Yaoze Liang; Zhenhua Huang
Journal:  World J Surg Oncol       Date:  2018-02-23       Impact factor: 2.754

Review 8.  Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.

Authors:  Xueyong Liu; Zhan Zhang; Chunbo Deng; Yihao Tian; Xun Ma
Journal:  Oncotarget       Date:  2017-07-19

9.  Genetic Variant of NFIB is Associated With the Metastasis of Osteosarcoma in Chinese Population.

Authors:  Leilei Xu; Jun Ni; Yongjie Wang; Yang Dong; Shoufeng Wang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

10.  Functional variant of IL33 is associated with survival of osteosarcoma patients.

Authors:  Qingxi Lin; Jingjing Han; Qi Sun; Li Wen; Shoufeng Wang
Journal:  J Bone Oncol       Date:  2019-12-02       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.